Published in PLoS One on March 15, 2013
Complete nucleotide sequence of cfr-carrying IncX4 plasmid pSD11 from Escherichia coli. Antimicrob Agents Chemother (2014) 0.84
First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone. Antimicrob Agents Chemother (2016) 0.83
Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol (2000) 34.08
Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother (2007) 3.96
Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol (2003) 3.51
Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother (2006) 2.92
Linezolid in vitro: mechanism and antibacterial spectrum. J Antimicrob Chemother (2003) 2.10
Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents (2004) 2.07
Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis (2010) 2.02
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob Agents Chemother (2009) 1.81
Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog (2010) 1.74
Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother (2008) 1.51
Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate. Antimicrob Agents Chemother (2010) 1.40
Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol (2008) 1.30
United States resistance surveillance results for linezolid (LEADER Program for 2007). Diagn Microbiol Infect Dis (2008) 1.24
Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4')-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain. Antimicrob Agents Chemother (2012) 1.04
Emergence and spread of cfr-mediated multiresistance in staphylococci: an interdisciplinary challenge. Future Microbiol (2011) 0.85
Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis (2009) 1.82
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections. J Infect (2009) 1.68
Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother (2003) 1.62
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother (2012) 1.56
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob Agents Chemother (2011) 1.54
Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort. Clin Infect Dis (2013) 1.52
Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med (2005) 1.50
Infected hip hemiarthroplasties and total hip arthroplasties: Differential findings and prognosis. J Infect (2013) 1.49
[Experimental meningitis due to a high-level cephalosporin-resistant strain of Streptococcus pneumoniae serotype 23F]. Enferm Infecc Microbiol Clin (2003) 1.40
[Impact of a prevention program for catheter-related bloodstream infection in the intensive care unit of a tertiary hospital]. Enferm Infecc Microbiol Clin (2009) 1.39
[Control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A survey from the MRSA 2003 GEIH/GEMARA/REIPI project]. Enferm Infecc Microbiol Clin (2006) 1.39
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus]. Enferm Infecc Microbiol Clin (2008) 1.39
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother (2004) 1.33
Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med (2004) 1.15
Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med (2008) 1.14
Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob Agents Chemother (2012) 1.13
Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother (2010) 1.12
Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides. J Antimicrob Chemother (2005) 1.11
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J Antimicrob Chemother (2006) 1.10
Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons. J Clin Microbiol (2010) 1.09
Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis. Antimicrob Agents Chemother (2003) 1.08
A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition. BMC Infect Dis (2011) 1.07
Epidemiological and clinical characteristics of bacteraemia caused by Aeromonas spp. as compared with Escherichia coli and Pseudomonas aeruginosa. Scand J Infect Dis (2004) 1.04
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother (2013) 1.01
Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother (2011) 1.00
Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit. J Clin Microbiol (2007) 1.00
Relationship between clinical and environmental isolates of Pseudomonas aeruginosa in a hospital setting. Arch Med Res (2004) 0.98
Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection. Int J Infect Dis (2010) 0.97
Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother (2010) 0.97
Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain. BMC Microbiol (2010) 0.92
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital. Medicine (Baltimore) (2011) 0.91
The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am J Med (2002) 0.91
[Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. Enferm Infecc Microbiol Clin (2009) 0.91
Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases. Clin Lymphoma Myeloma (2008) 0.90
Levofloxacin treatment failure in Haemophilus influenzae pneumonia. Emerg Infect Dis (2003) 0.88
Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J Infect (2009) 0.88
Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes. Antimicrob Agents Chemother (2005) 0.88
Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus ST398 resistant to tetracycline at a Spanish hospital over 12 years. PLoS One (2013) 0.86
Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS One (2013) 0.86
A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections. Microb Drug Resist (2004) 0.86
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation (2013) 0.86
[Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)]. Enferm Infecc Microbiol Clin (2008) 0.85
Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients. AIDS Rev (2010) 0.85
Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. J Antimicrob Chemother (2006) 0.84
Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients. Transplantation (2015) 0.84
Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection. J Infect (2008) 0.84
Contribution of capsular and clonal types and beta-lactam resistance to the severity of experimental pneumococcal meningitis. Microbes Infect (2007) 0.81
Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain. J Clin Microbiol (2006) 0.81
[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]. Enferm Infecc Microbiol Clin (2011) 0.80
Community-associated methicillin-resistant Staphylococcus aureus infections in HIV-infected patients in Spain. J Infect (2012) 0.80
[Surveillance and control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A GEIH-SEIMC and SEMPSPH consensus document]. Enferm Infecc Microbiol Clin (2008) 0.79
Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother (2003) 0.79
Evaluation of antimicrobial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa. Microbes Infect (2007) 0.78
[Community-onset and nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus in Spanish hospitals]. Enferm Infecc Microbiol Clin (2009) 0.77
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Support Care Cancer (2013) 0.77
Bacteremia related with arterial catheter in critically ill patients. J Infect (2011) 0.76
Epidemiology of surgical site infections after total hip and knee joint replacement during 2007-2009: a report from the VINCat Program. Enferm Infecc Microbiol Clin (2012) 0.76
Clonal spread of Klebsiella pneumoniae producing OXA-1 betalactamase in a Spanish hospital. Int Microbiol (2013) 0.76
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus. Emerg Infect Dis (2016) 0.76
Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. J Antimicrob Chemother (2005) 0.75
Integron presence in a multiresistant Morganella morganii isolate. Int J Antimicrob Agents (2006) 0.75
[The clinical significance of broad-spectrum beta-lactamases]. Enferm Infecc Microbiol Clin (2003) 0.75
Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010). Rev Esp Quimioter (2011) 0.75
[Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. Enferm Infecc Microbiol Clin (2007) 0.75
An african-born man with chronic recurrent hemoptysis. Clin Infect Dis (2008) 0.75
Device-associated infection rates in Adult Intensive Care Units in Catalonia: VINCat Program findings. Enferm Infecc Microbiol Clin (2012) 0.75
[Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)]. Enferm Infecc Microbiol Clin (2003) 0.75
[Urinary tract infection caused by Corynebacterium riegelii]. Enferm Infecc Microbiol Clin (2008) 0.75
Takayasu arteritis and pregnancy from the point of view of the internist. J Rheumatol (2009) 0.75
[Importance of geriatric centres or long-stay health institutions due to the endemic persistence of MRSA]. Enferm Infecc Microbiol Clin (2011) 0.75
The development and successful implementation of the VINCat Program. Enferm Infecc Microbiol Clin (2012) 0.75
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ]. Enferm Infecc Microbiol Clin (2009) 0.75
[Impact and control of methicillin-resistant Staphylococcus aureus (MRSA) in long-term care facilities]. Rev Esp Geriatr Gerontol (2008) 0.75
[Necrotizing fasciitis and bacteriemia]. Enferm Infecc Microbiol Clin (2005) 0.75
[Epidemiological surveillance cultures in antimicrobial-resistant bacteria causing nosocomial infection]. Enferm Infecc Microbiol Clin (2008) 0.75
Thrombolysis in elderly patients with massive pulmonary embolism. J Am Geriatr Soc (2008) 0.75
High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy. J Infect (2009) 0.75
Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) in acute care hospitals. Results of the VINCat Program (2008-2010). Enferm Infecc Microbiol Clin (2012) 0.75
[Monitoring plasma antibiotic concentrations in Spanish hospitals]. Enferm Infecc Microbiol Clin (2006) 0.75